TRUMBULL, Conn., May 28, 2020 /PRNewswire/ -- ZetrOZ Systems
is pleased to announce the selection of Dr. George Lewis as a keynote speaker at the 2020
National Institutes of Health Pain Consortium Symposium. This
year's event will be held virtually and focus on breakthrough
technologies that improve the understanding of pain and the ways to
manage it.
Dr. Lewis will speak about Sustained Acoustic
Medicine (sam®), wearable long-duration ultrasound
in the treatment of chronic pain from overuse injuries and joint
arthritis. sam® is the only FDA-cleared prescription
home-use medical device that uses ultrasonic waves over multiple
hours to increase circulation, modulate cellular activity and
reduce pain. The non-invasive, targeted, and opioid-free
sam® treatment is based on a decade of multi-site
collaborative research studies across the
United States. The presentation will review the clinical
literature and mechanisms of action behind the sam®
treatment algorithm, including how the treatment inhibits
inflammatory pathways and stimulates soft tissue repair in common
chronic pain conditions. Additionally, the presentation will
discuss new emerging research with sam® as a localized
drug delivery approach to improve the efficacy of common
nonsteroidal anti-inflammatory drugs in the safe management of
chronic pain.
"Recent clinical studies supported by the National
Institutes of Health have shown that Sustained Acoustic Medicine
can reduce moderate to severe knee arthritis pain by 70% in one
week," explains Dr. Lewis. "The daily long-duration ultrasound
treatment is safe and clinically proven on upper neck, shoulder and
back pain, and arthritis." Dr. Lewis continued, "sam®
gives healthcare providers and patients a safe and effective
alternative to surgery and opioid pain medication, and we are
continuing to study novel dosing regimens to further improve our
medical products and portfolio of offerings."
Dr. George Lewis is the President
of ZetrOZ Systems, a global healthcare company that develops and
manufactures non-invasive medical devices to accelerate tissue
healing and relieve pain for chronic musculoskeletal
conditions.
Over his last decade leading ZetrOZ Systems, Dr. Lewis has
developed three distinctly unique medical devices -
UltrOZ®, sam® Sport and sam® Pro
2.0 - into the healthcare ecosystem. sam®, in
particular, has been broadly adopted for its ability to accelerate
soft tissue healing and reduce pain without requiring surgery or
narcotics. The device uses ultrasound to heal soft tissue damage,
joint damage, and treat arthritis. sam® has been
authorized by many health plans and insurance carriers in
the United States including the
United States Department of Defense (DOD) and the Veterans
Administration.
"The use of sam® home-use durable medical equipment
typically costs the healthcare system $8,000 to $12,000
dollars, which is not insignificant. However, since it does
not have the inherent surgical costs and long-term comorbidities of
narcotics, it saves the healthcare system well over $30,000 per patient," said Dr. Lewis. "Since the
sam® device can ship directly to the patient's home like
a pharmaceutical, many healthcare providers have chosen
sam® instead of elective surgery to manage their
patients' pain during COVID-19."
Prior to founding ZetrOZ Systems, Dr. Lewis was a Presidential
Life Science Fellow, a National Science Foundation Fellow and
United States Senate Page in
Washington, D.C. He has authored
more than 50 peer-reviewed publications and abstracts and has filed
over 60 global patents. Dr. Lewis graduated summa cum laude in
biomedical engineering from the University of
Miami, Florida and received his doctorate from Cornell University, New
York.
About ZetrOZ Systems
ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology
company headquartered in the southern coastal region of
Connecticut. The organization also
has manufacturing facilities across the
United States. ZetrOZ produced UltrOZ®,
sam®Sport and sam®Pro 2.0 to provide safe and
effective treatment options for prevalent conditions such as
arthritis. Learn more at zetroz.com and samrecover.com.
View original
content:http://www.prnewswire.com/news-releases/zetroz-systems-announces-dr-george-lewis-to-speak-at-the-2020-national-institutes-of-health-pain-consortium-symposium-301067093.html
SOURCE ZetrOZ Systems